Search Results - "Derache, N"

Retrospective evaluation of regional telemedicine team meetings for multiple sclerosis (MS) patients: Experience from the Caen MS expert center in Normandy, France by Derache, N., Hauchard, K., Seguin, F., Ohannessian, R., Defer, G.

“…Multiple sclerosis (MS) is a demyelinating disease requiring multidisciplinary care coordination. Recent development of diagnosis criteria and disease…”
Get full text

French consensus procedure for neuropsychological assessment in multiple sclerosis by Jougleux, C., Joly, H., Brissard, H., Lenne, B., François, S., Hamelin, F., Derache, N., Morin, J., Reuter, F., Colamarino, R., Ruet, A.

“…Cognitive impairment is one of the invisible symptoms of Multiple sclerosis (MS), which could be associated with depression, unemployment, reduced social…”
Get full text

Organization of care for multiple sclerosis in France by Derache, N., Dufay, A., Lebarbey, C.

“…Multiple sclerosis (MS) is a disease with a number of aspects involving cooperation among many caregivers. In France, the organization of care for patients…”
Get full text

Treatment of neuromyelitis optica with rituximab: a 2-year prospective multicenter study by Cabre, Philippe, Mejdoubi, M., Jeannin, S., Merle, H., Plumelle, Y., Cavillon, G., Smadja, D., Marignier, R.

“…Objective Neuromyelitis optica (NMO) is a very severe autoimmune disorder of the central nervous system. It affects young subjects and has a poor prognosis…”
Get full text

Isolated tumefactive demyelinating lesions: diagnosis and long-term evolution of 16 patients in a multicentric study by Siri, A., Carra-Dalliere, Clarisse, Ayrignac, X., Pelletier, J., Audoin, B., Pittion-Vouyovitch, S., Debouverie, M., Lionnet, C., Viala, F., Sablot, D., Brassat, D., Ouallet, J.-C., Ruet, A., Brochet, B., Taillandier, L., Bauchet, L., Derache, N., Defer, G., Cabre, P., de Seze, J., Lebrun Frenay, C., Cohen, M., Labauge, P.

“…Isolated tumefactive demyelinating lesion (TDL) is a rare disease and a challenging entity especially for the differential diagnosis, biopsy indications, and…”
Get full text

A prospective observational post-marketing study of natalizumab-treated multiple sclerosis patients: clinical, radiological and biological features and adverse events. The BIONAT cohort by Outteryck, O., Ongagna, J.C., Brochet, B., Rumbach, L., Lebrun-Frenay, C., Debouverie, M., Zéphir, H., Ouallet, J.C., Berger, E., Cohen, M., Pittion, S., Laplaud, D., Wiertlewski, S., Cabre, P., Pelletier, J., Rico, A., Defer, G., Derache, N., Camu, W., Thouvenot, E., Moreau, T., Fromont, A., Tourbah, A., Labauge, P., Castelnovo, G., Clavelou, P., Casez, O., Hautecoeur, P., Papeix, C., Lubetzki, C., Fontaine, B., Couturier, N., Bohossian, N., Clanet, M., Vermersch, P., de Sèze, J., Brassat, D.

“…Background and purpose BIONAT is a French multicentric phase IV study of natalizumab (NTZ)‐treated relapsing−remitting multiple sclerosis (MS) patients. The…”
Get full text

High-risk syndrome for neuromyelitis optica: a descriptive and comparative study by Collongues, N, Marignier, R, Zéphir, H, Blanc, F, Vukusic, S, Outteryck, O, Fleury, M, Ruet, A, Borgel, F, Thouvenot, E, Moreau, T, Defer, G, Derache, N, Pelletier, J, Audoin, B, Debouverie, M, Labauge, P, Gout, O, Camu, W, Brassat, D, Brochet, B, Vermersch, P, Confavreux, C, Seze, J de

“…Background: Neuromyelitis optica (NMO) frequently begins with a monofocal episode of optic neuritis or myelitis. A concept named high-risk syndrome (HRS) for…”
Get full text

Unusual presentation of CADASIL with reversible coma and confusion by LE BER, I, CARLUER, L, DERACHE, N, LALEVEE, C, LEDOZE, F, DEFER, G. L

Get full text

Therapeutic management of cognitive disorders in multiple sclerosis by Defer, G-L, Daniel, F, Derache, N

“…Taking in charge cognitive disorders is a new concept in the global care of MS patients. Cognitive disorders are observed in the all forms of the disease,…”
Get full text

Comparative effectiveness of teriflunomide vs dimethyl fumarate in multiple sclerosis by Laplaud, David-Axel, Casey, Romain, Barbin, Laetitia, Debouverie, Marc, De Sèze, Jérôme, Brassat, David, Wiertlewski, Sandrine, Brochet, Bruno, Pelletier, Jean, Vermersch, Patrick, Edan, Gilles, Lebrun-Frenay, Christine, Clavelou, Pierre, Thouvenot, Eric, Camdessanché, Jean-Philippe, Tourbah, Ayman, Stankoff, Bruno, Al Khedr, Abdullatif, Cabre, Philippe, Lubetzki, Catherine, Papeix, Caroline, Berger, Eric, Heinzlef, Olivier, Debroucker, Thomas, Moreau, Thibault, Gout, Olivier, Bourre, Bertrand, Wahab, Abir, Labauge, Pierre, Magy, Laurent, Defer, Gilles, Guennoc, Anne-Marie, Maubeuge, Nicolas, Labeyrie, Céline, Patry, Ivania, Nifle, Chantal, Casez, Olivier, Michel, Laure, Rollot, Fabien, Leray, Emmanuelle, Vukusic, Sandra, Foucher, Yohann, Fontaine, B, Marignier, R, Durand-Dubief, F, Mathey, G, Le Page, E, Peaureaux-Averseng, D, Ouallet, J.C, Ruet, A, Collongues, N, Hautecoeur, P, Zephir, H, Maillard, E, Cohen, M, Derache, N, Branger, P, Ayrignac, X, Carra-Dalliere, C, Fromont, A, Chamard-Witkowski, L, Taithe, F, Moisset, X, Audoin, B, Rico-Lamy, A, Castelnovo, G, Giannesini, C, Fagniez, O, Bensa, C, Gueguen, A, Kasonde, I Tabellah, De Vilmarest, A, Montcuquet, A, Vaillants, M, Beltran, S, Creange, A, Ayache, S, Abdellaoui, M, Pottier, C, Slesari, I, Deburghraeve, V, Neau, J.P, Servan, J, Pico, F, Henry, C, Hankiewicz, K

“…OBJECTIVEIn this study, we compared the effectiveness of teriflunomide (TRF) and dimethyl fumarate (DMF) on both clinical and MRI outcomes in patients followed…”
Get full text

Comparative efficacy of fingolimod vs natalizumab: A French multicenter observational study by Barbin, Laetitia, Rousseau, Chloe, Jousset, Natacha, Casey, Romain, Debouverie, Marc, Vukusic, Sandra, De Sèze, Jerome, Brassat, David, Wiertlewski, Sandrine, Brochet, Bruno, Pelletier, Jean, Vermersch, Patrick, Edan, Gilles, Lebrun-Frenay, Christine, Clavelou, Pierre, Thouvenot, Eric, Camdessanché, Jean-Philippe, Tourbah, Ayman, Stankoff, Bruno, Al Khedr, Abdullatif, Cabre, Philippe, Papeix, Caroline, Berger, Eric, Heinzlef, Olivier, Debroucker, Thomas, Moreau, Thibault, Gout, Olivier, Bourre, Bertrand, Créange, Alain, Labauge, Pierre, Magy, Laurent, Defer, Gilles, Foucher, Yohann, Laplaud, David A

“…To compare natalizumab and fingolimod on both clinical and MRI outcomes in patients with relapsing-remitting multiple sclerosis (RRMS) from 27 multiple…”
Get full text

Adverse Drug Reaction Reporting Using a Mobile Device Application by Persons with Multiple Sclerosis: A Cluster Randomized Controlled Trial by Defer, Gilles, Fedrizzi, Sophie, Chevanne, Damien, Montastruc, François, Briant, Anais R., Parienti, Jean-Jacques, Peyro-Saint-Paul, Laure

“…Introduction Patient reporting adds value to pharmacovigilance. Encouraging it to be done through a mobile device application (App) is a method that should be…”
Get full text

Influence of Emotional Valence on Verbal Episodic Memory in Multiple Sclerosis (P04.110) by Derache, N., Mondou, A., Makouri, R., Desgranges, B., Defer, G.

“…Abstract only…”
Get full text

Infections and multiple sclerosis: Recommendations from the French Multiple Sclerosis Society by Papeix, C., Donze, C., Lebrun-Frénay, C., Papeix, C., Donzé, C., Lebrun-Frénay, C., Laplaud, D., Thouvenot, E., Ayrignac, X., Pourcher-Martinez, V., Zéphir, H., de Seze, J., Michel, L., Bensa, C., Cara-Dalliere, C., Guen-noc, A.M., Casez, O., Maarouf, A., Bourre, B., Kwiatkowski, A., Cohen, M., Maillart, E., Collongues, N., Louapre, C., Androdias, G., Guegen, A., Audoin, B., Mattey, G., Bernady, P., Faucheux, J.M., Labauge, P., Meckies, C., Stankoff, B., Tourniaire, P., Dinh, A., Guennoc, A.M., Durnad-Dubief, F., Wiertlewski, S., Derache, N., Le page, E., Pittion, S., Vukusic, S., Clavelou, P., Heinzlef, O., Colamarino, R., Planque, E., Rico, A., Sheiber nogueira, C., de Seze, M., Ciron, J., Alchaar, H., Bensmail, D., Biotti, D., Branger, P., Brochet, B., Castan, B., Creange, A., Creisson, E., DeBroucker, T., Depaz, R., Douay, X., Dulau, C., Faucher, M., Fournier, M., Fromont, A., Gallien, P., Gout, O., Grimaud, J., Hervé, Y., Kerbrat, A., Kremer, L., Lanotte, L., Magy, L., Mania, A., Maurousset, A., Moisset, X., Montcuquet, A., Moreau, T., Morel, N., Patry, I., Peaureaux, D., Pouget, M.C., Ruet, A., Saint-Val, C., Stahl, J.P., Taithe, F., Tattevin, P., Vaillant, M., Vuoto, F.

“…Viral, bacterial, or fungal infections are suspected of triggering multiple sclerosis (MS) and promoting relapses of the disease and are likely to be promoted…”
Get full text

Urinary tract infections and multiple sclerosis: Recommendations from the French Multiple Sclerosis Society by Papeix, C., Lebrun-Frenay, C., Donzé, C., Papeix, C., Lebrun-Frénay, C., Collongues, N., de Seze, M., Dinh, A., Even, A., Scheiber-Nogueira, C., Bourre, B., Carra-Dallière, C., Ciron, J., Cohen, M., Guennoc, A.M., Lebreton, F., Michel, L., Maillart, E., Audoin, B., Ayrignac, X., Bernady, P., Brochet, B., Clavelou, P., Declemy, A., de Seze, J., Derache, N., Faucheux, J.-M., Heinzlef, O., Labauge, P., Laplaud, D., Lepage, E., Leray, E., Magy, L., Mathey, G., Mekies, C., Mondain, V., Planque, E., Pelletier, J., Pittion, S., Stankhof, B., Tournaire, P., Thouvenot, E., Vukusic, S., Wiertlevski, S., Zephir, H., Androdias, G., Benazet, M., Bensmail, D., Blanchard-Dauphin, A., Bonnan, M., Boutière, C., Branger, P., Bresch, S., Bru, J.-P., Camdessanché, J.-P., Castel Canal, E., Coustans, M., Creange, A., Creisson, E., De Broucker, T., Depaz, R., Douay, X., Dulau, C., Durand-Dubief, F., Fagniez, O., Floch, A., Fournier, M., Fromont, A., Gallien, P., Gamé, X., Gault, D., Gayou, A., Giroux, M., Gout, O., Grimaud, J., Hautecoeur, P., Kerbrat, A., Kwiatkowski, A., Lachaud, S., Lanotte, L., Manchon, E., Michel, L., Milor, A.-M., Moisset, X., Mont-Cuquet, A., Moreau, T., Ouallet, J.-C., Patry, I., Peaureaux, D., Pouget, M.-C., Pourcher Martinez, V., Radot, C., Ruet, A., Saint-Val, C., Taithe, F., Tatevin, P., Vaillant, M., Stahl, J.-P., Vuoto, F., Zaenker, C.

“…Establish recommendations for the management of UTIs in MS patients. Urinary tract infections (UTIs) are common during multiple sclerosis (MS) and are one of…”
Get full text

Increase of Infusion Interval Do Not Impair Natalizumab Efficacy in RR-MS Patients: A Pilot Study Based on Monthly Monitoring of CD49d (P06.166) by Defer, G., Mariotte, D., Derache, N., Toutirais, O., Lamotte, G., Legros, H., Cauquelin, B., Le Mauff, B.

“…Abstract only…”
Get full text

Cas cliniques by Derache, N., Collongues, N., Casez, O.

Get full text

Atteinte multiple des nerfs crâniens et méningite : leucémie lymphoïde chronique et/ou maladie de Lyme : à propos d’un cas by Tordjman, M.-A., Chantepie, S., Defer, G., Derache, N.

Get full text

Application des critères MacDonald 2010 pour le diagnostic de sclérose en plaques à une cohorte de patients présentant un syndrome cliniquement isolé médullaire by Vandendriessche, A., Zephir, H., Vermersch, P., De Seze, J., Derache, N., Maltete, D., Bourre, B.

Get full text

Influence de l’émotion sur la mémoire épisodique dans la sclérose en plaques by Lefilliatre, M., Mondou, A., Makouri, R., Desgranges, B., Derache, N., Defer, G.

Get full text